Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JPA, JSMI to Regularly Exchange Opinions on Class 1 OTC Drugs
January 28, 2008
- TOPICS／J&J to Advertise Nicorette in Taxis
January 28, 2008
- TOPICS／T. Dooley Elected Chairman of Japan Intraocular Lens Association
January 28, 2008
- BUSINESS NEWS IN BRIEF
January 28, 2008
- SELF-MEDICATION NEWS IN BRIEF
January 28, 2008
- Aiming at Sales of \100 Billion: Sawai
January 28, 2008
- TOPICS／Pfizer Auctions Unneeded Equipment via the Internet
January 28, 2008
- Sales Up 10.5%, Ordinary Profits Up 28.8%: Nichi-Iko
January 28, 2008
- New Sekisui Medical Aims at Sales of \50 Bil in FY2011
January 28, 2008
- Nippon Kayaku Aims at Sales of \10 Bil with Generic Anticancer Drugs
January 28, 2008
- MEDICAL DEVICE NEWS IN BRIEF
January 28, 2008
- Efforts of All Companies Required to Improve Reliability of Generics: JGPMA President Mr Sawai
January 28, 2008
- 24 "Advanced Healthcare Services" Recommended for Insurance Coverage
January 28, 2008
- Pharmacists Must Make Greater Efforts to Dispense Generics: JPA Vice president
January 28, 2008
- Chuikyo Subcommittee Resumes Discussions on Medical Fees
January 28, 2008
- MEXT Starts Full Discussions to Promote iPS Cell Research
January 28, 2008
- Gov't and Drug-Related Hepatitis Victims Agree on Settlement
January 28, 2008
- Korosho, MEXT, METI to Work Together to Promote iPS Cell Research
January 28, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 28, 2008
- R&D NEWS IN BRIEF
January 21, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…